We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+1.61%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$94B
AUM Growth
-$5.55B
Cap. Flow
-$6.11B
Cap. Flow %
-6.5%
Top 10 Hldgs %
18.25%
Holding
5,056
New
758
Increased
1,544
Reduced
1,769
Closed
869

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.52B
2
AVGO icon
Broadcom
AVGO
+$409M
3
NOW icon
ServiceNow
NOW
+$359M
4
TSLA icon
Tesla
TSLA
+$230M
5
TMUS icon
T-Mobile US
TMUS
+$219M

Sector Composition

Rank Sector Weight
1 Technology 11.46%
2 Consumer Discretionary 6.93%
3 Industrials 5.09%
4 Financials 5.05%
5 Healthcare 4.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPK icon
4001
CALL
Opko Health
OPK
$921M
$117K ﹤0.01%
92,500
NMFC icon
4002
New Mountain Finance
NMFC
$646M
$116K ﹤0.01%
+12,597
New +$119K
LRMR icon
4003
Larimar Therapeutics
LRMR
$416M
$116K ﹤0.01%
+30,416
New +$118K
CATO icon
4004
Cato Corp
CATO
$65.9M
$114K ﹤0.01%
36,771
-12,512
-25% -$46K
ANY icon
4005
Sphere 3D
ANY
$14.6M
$113K ﹤0.01%
+38,121
New +$228K
TV icon
4006
Televisa
TV
$1.45B
$113K ﹤0.01%
38,683
+7,176
+23% +$19.6K
IMMX icon
4007
Immix Biopharma
IMMX
$607M
$112K ﹤0.01%
+21,500
New +$88.5K
RLJ icon
4008
RLJ Lodging Trust
RLJ
$1.87B
$112K ﹤0.01%
15,073
-19,227
-56% -$140K
INGN icon
4009
Inogen
INGN
$167M
$112K ﹤0.01%
16,682
-19,629
-54% -$147K
CADL icon
4010
Candel Therapeutics
CADL
$700M
$112K ﹤0.01%
19,737
-11,225
-36% -$60.4K
SEER icon
4011
Seer Inc
SEER
$108M
$111K ﹤0.01%
60,884
-31,022
-34% -$63.3K
GETY icon
4012
Getty Images
GETY
$184M
$111K ﹤0.01%
83,000
+56,380
+212% +$97K
FSM icon
4013
PUT
Fortuna Silver Mines
FSM
$2.59B
$111K ﹤0.01%
11,300
KREF
4014
KKR Real Estate Finance Trust
KREF
$472M
$111K ﹤0.01%
+13,466
New +$114K
CRON
4015
Cronos Group
CRON
$1.05B
$110K ﹤0.01%
+41,669
New +$108K
LUMN icon
4016
PUT
Lumen
LUMN
$6.53B
$109K ﹤0.01%
14,000
-28,600
-67% -$235K
LCTX icon
4017
Lineage Cell Therapeutics
LCTX
$257M
$109K ﹤0.01%
+65,109
New +$113K
BRLT icon
4018
Brilliant Earth
BRLT
$18.5M
$109K ﹤0.01%
62,103
+22,793
+58% +$48.4K
HLLY icon
4019
Holley
HLLY
$314M
$107K ﹤0.01%
26,014
-129,343
-83% -$466K
SERA icon
4020
Sera Prognostics
SERA
$80.3M
$107K ﹤0.01%
36,322
-56,741
-61% -$183K
KYNB
4021
Kyntra Bio
KYNB
$28.5M
$107K ﹤0.01%
12,186
-4,184
-26% -$40.9K
STEX
4022
Streamex Corp
STEX
$76.7M
$107K ﹤0.01%
35,298
+23,085
+189% +$103K
CBAT icon
4023
CBAK Energy Technology Ltd
CBAT
$46.3M
$106K ﹤0.01%
+126,404
New +$116K
VWAV
4024
VisionWave Holdings
VWAV
$81.6M
$105K ﹤0.01%
+11,353
New +$118K
EMPD
4025
Empery Digital
EMPD
$94.2M
$104K ﹤0.01%
22,786
+1,225
+6% +$7.17K

Similar funds

Squarepoint's Q4 2025 Portfolio in Review

As of Q4 2025, Squarepoint held 5,056 positions worth $94B, down 5.6% from $99.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Squarepoint withdrew a net $6.11B in Q4 2025, closing 869 positions and reducing 1,769 holdings. Its most notable exit was State Street Communication Services Select Sector SPDR ETF, an estimated $328M position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Squarepoint opened a new position in Medline Inc worth $79.8M.

  • Squarepoint's largest Q4 2025 buy was Medline Inc: 1,900,000 shares worth $79.8M.
  • Squarepoint added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $1.52B increase.
  • Squarepoint's biggest Q4 2025 reduction was Walmart Inc, cutting an estimated $253M.
  • Squarepoint fully exited State Street Communication Services Select Sector SPDR ETF in Q4 2025, selling an estimated $328M.
  • Squarepoint's ten largest holdings make up 18% of its $94B portfolio in Q4 2025.
  • Squarepoint opened 758 new positions and closed 869 in Q4 2025.
  • Squarepoint's portfolio value fell 5.6% quarter-over-quarter to $94B.

Based on Squarepoint's 13F filing for Q4 2025, filed 13 Feb 2026.